Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia ; volume:8 ; number:1 ; day:8 ; month:5 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (8.5.2018), 1-10, 12.2018
- Creator
-
Wang, Yung-Chih
- Contributor
-
Huang, Tzu-Wen
Yang, Ya-Sung
Kuo, Shu-Chen
Chen, Chung-Ting
Liu, Chang-Pan
Liu, Yuag-Meng
Chen, Te-Li
Chang, Feng-Yee
Wu, Shih-Hsiung
How, Chorng-Kuang
Lee, Yi-Tzu
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25661-9
- URN
-
urn:nbn:de:101:1-2018070500314377846733
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Yung-Chih
- Huang, Tzu-Wen
- Yang, Ya-Sung
- Kuo, Shu-Chen
- Chen, Chung-Ting
- Liu, Chang-Pan
- Liu, Yuag-Meng
- Chen, Te-Li
- Chang, Feng-Yee
- Wu, Shih-Hsiung
- How, Chorng-Kuang
- Lee, Yi-Tzu
- SpringerLink (Online service)
Other Objects (12)
Acinetobacter baumannii biofilm and its potential therapeutic targets
Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii
Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii
Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia
Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
Ciprofloxacin- and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumannii
Acinetobacter baumannii biofilm and its potential therapeutic targets
Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii
Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii
Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia
Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
Ciprofloxacin- and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumannii
Acinetobacter baumannii biofilm and its potential therapeutic targets
Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii
Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii
Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia
Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis